<DOC>
	<DOCNO>NCT00825539</DOCNO>
	<brief_summary>Part 1 study assess enhancement task-related brain activation ( BOLD response ) key brain area schizophrenia performance work memory , episodic memory visual activation task measure functional magnetic resonance imaging ( fMRI ) people schizophrenia . Part 2 study ass safety tolerability multiple dose AQW051 people schizophrenia .</brief_summary>
	<brief_title>Pharmacodynamic/Pharmacokinetic Study AQW051 Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>1 . Diagnosis schizophrenia accord Diagnostic Statistical Manual Mental Disorders IV ( DSM IV/DSM IV TR ) 2 . Subjects currently treat stable regimen one follow second generation antipsychotic : olanzapine , risperidone , paliperidone , quetiapine , ziprasidone , aripiprazole . 3 . Subjects meet follow symptom criterion : Brief Psychiatric Rating Scale ( BPRS ) Hallucinatory Behavior Unusual Thought Content item score less equal 5 BPRS Conceptual Disorganization item score less equal 4 SimpsonAngus Scale ( SAS ) total score less equal 6 Calgary Depression Scale ( CDS ) total score less equal 10 4 . Subjects meet following cognitive performance criterion : Maximum performance level : Performance 1.0 SD perfect performance Hopkins Verbal Learning Test ( HVLT ) total ( 31 less ) , Minimum performance level : subject must able validly complete fMRI cognitive paradigms WTAR : 5th grade read level assessment 5 . Subjects must symptomatically stable suffer acute exacerbation psychosis 6 . Female subject childbearing potential must use two acceptable method contraception , ( e.g. , intrauterine device plus condom , spermicidal gel plus condom , diaphragm plus condom , etc . ) , time screen duration study , study completion . Pregnancy test require female subject regardless report sterilization . When perform screen practice visit , result test must receive subject may dose . 7 . Male subject must use two acceptable method contraception , ( e.g. , spermicidal gel plus condom ) entire duration studyuntil Study Completion visit . 8 . Subject must sufficiently stable overall health , determine Investigator . The regular intake concomitant drug allow , patient stable treatment least 3 month prior study enrollment concomitant drug belong list medication allow accord Appendix 3 . If patient take one concomitant medication , Investigator 's discretion decide patient 's eligibility , depend nature concomitant medication patient 's overall health . Exclusion criterion : 1 . Current treatment conventional antipsychotic ( e.g . fluphenazine , haloperidol ) clozapine 2 . Current treatment anticholinergic agent know adversely interfere cholinergic system 3 . Subjects DSMIV diagnosis substance abuse ( nicotine ) within last month . 4 . Subjects history significant head injury/trauma , define : Loss consciousness ( LOC ) 1 hour Recurring seizure result head injury Clear cognitive sequelae injury Cognitive rehabilitation follow injury 5 . Subjects medical neurological disorder treatment disorder could interfere study medication assessment subject 6 . Use certain concomitant medication No grapefruit grapefruit juice consume 14 day prior dose 7 day follow last dose . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Manic depression</keyword>
	<keyword>anxiety</keyword>
</DOC>